Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scaffolds for engineering novel binding sites in proteins

P A Nygren1, M Uhlén

  • 1Department of Biochemistry and Biotechnology, Royal Institute of Technology (KTH), Stockholm, Sweden. perake@biochem.kth.se

Current Opinion in Structural Biology
|August 1, 1997
PubMed
Summary

Novel protein ligands were developed using protein chemistry and selection techniques. These engineered binding proteins show potential to replace antibodies in biotechnology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A human stomach cell type transcriptome atlas.

BMC biology·2024
Same author

Untargeted screening for novel autoantibodies with prognostic value in first-episode psychosis.

Translational psychiatry·2017
Same author

The gene for staphylococcal protein A.

Immunology today·2014
Same author

The human testis-specific proteome defined by transcriptomics and antibody-based profiling.

Molecular human reproduction·2014
Same author

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

British journal of cancer·2013
Same author

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer.

British journal of cancer·2012

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • Protein engineering enables the development of novel biomolecules.
  • Natural antibodies are widely used but have limitations.

Purpose of the Study:

  • To develop novel protein ligands with specific binding capabilities.
  • To explore alternatives to natural antibodies in biotechnological applications.

Main Methods:

  • Utilized combinational protein chemistry techniques.
  • Employed powerful selection methods for target binding.
  • Randomized surface residues of a parental protein scaffold.

Main Results:

  • Successfully developed novel protein ligands.

Related Experiment Videos

  • Demonstrated specific binding towards target ligands.
  • Identified potential antibody replacements.

    • Conclusions:

    • Engineered protein ligands offer a promising alternative to natural antibodies.
    • This approach has broad biotechnological applications.